SUV39H1 and endothelial dysfunction: Interestingly, among alterations to the three H3K9-modifying enzymes, the downregulation of SUV39H1 induced by obesity is central to H3K9 modification on the p66Shc promoter, leading to ROS-induced endothelial dysfunction and the development of atherosclerosis [34].